It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The relationship between age and seroprevalence can be used to estimate the annual attack rate of an infectious disease. For pathogens with multiple serologically distinct strains, there is a need to describe composite exposure to an antigenically variable group of pathogens. In this study, we assay 24,402 general-population serum samples, collected in Vietnam between 2009 to 2015, for antibodies to eleven human influenza A strains. We report that a principal components decomposition of antibody titer data gives the first principal component as an appropriate surrogate for seroprevalence; this results in annual attack rate estimates of 25.6% (95% CI: 24.1% – 27.1%) for subtype H3 and 16.0% (95% CI: 14.7% – 17.3%) for subtype H1. The remaining principal components separate the strains by serological similarity and associate birth cohorts with their particular influenza histories. Our work shows that dimensionality reduction can be used on human antibody profiles to construct an age-seroprevalence relationship for antigenically variable pathogens.
Multi-strain pathogens, such as influenza, present challenges for interpretation of seroprevalence data as estimates may vary by strain. Here, the authors develop a method for estimating age-specific seroprevalence based on principal components analysis and apply it to influenza data from Vietnam.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details








1 Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam (GRID:grid.412433.3) (ISNI:0000 0004 0429 6814)
2 Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam (GRID:grid.412433.3) (ISNI:0000 0004 0429 6814); University of Oxford, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); Pennsylvania State University, Center for Infectious Disease Dynamics, Department of Biology, University Park, USA (GRID:grid.29857.31) (ISNI:0000 0001 2097 4281)
3 Erasmus Medical Centre, Department of Viroscience, Rotterdam, Netherlands (GRID:grid.5645.2) (ISNI:000000040459992X)
4 Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam (GRID:grid.412433.3) (ISNI:0000 0004 0429 6814); Liverpool School of Tropical Medicine, Liverpool, UK (GRID:grid.48004.38) (ISNI:0000 0004 1936 9764); Liverpool University Hospitals NHS Foundation Trust, Tropical and Infectious Disease Unit, Liverpool, England (GRID:grid.10025.36) (ISNI:0000 0004 1936 8470)
5 Hue Provincial Hospital, Hue, Vietnam (GRID:grid.412433.3)
6 Khanh Hoa Provincial Hospital, Nha Trang, Vietnam (GRID:grid.412433.3)
7 Dak Lak General Hospital, Buon Ma Thuot, Vietnam (GRID:grid.412433.3)
8 National Institute of Hygiene and Epidemiology, Hanoi, Vietnam (GRID:grid.419597.7) (ISNI:0000 0000 8955 7323)
9 Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam (GRID:grid.412433.3) (ISNI:0000 0004 0429 6814); University of Oxford, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)
10 Pennsylvania State University, Center for Infectious Disease Dynamics, Department of Biology, University Park, USA (GRID:grid.29857.31) (ISNI:0000 0001 2097 4281)
11 Monash University, Institute of Vector Borne Disease, Melbourne, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857)
12 Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam (GRID:grid.412433.3) (ISNI:0000 0004 0429 6814); University of Oxford, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431)
13 Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam (GRID:grid.414273.7)